Cell and gene therapy insights and what to expect in 2021


Working together with other stakeholders to define the operational processes and systems for new standards of care gives us an informed and broad perspective on what’s next for CGT and the value chain.


Learn from Heidi Hagen, Co-found and Advisor to Vineti and one of our collaborators, Cardinal Health Speciality Solutions, on our seven commercialization trends that are likely to shape the CGT market. Additionally, we discuss practical steps to accelerate not just approval, but adoption of these innovative therapies.